
SEL24-B489
CAS No. 1616359-00-2
SEL24-B489( SEL24 )
Catalog No. M12358 CAS No. 1616359-00-2
SEL24-B489 (SEL24) is a potent, dual PIM and FLT3-ITD inhibitor.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 374 | Get Quote |
![]() ![]() |
100MG | Get Quote | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameSEL24-B489
-
NoteResearch use only, not for human use.
-
Brief DescriptionSEL24-B489 (SEL24) is a potent, dual PIM and FLT3-ITD inhibitor.
-
DescriptionSEL24-B489 (SEL24) is a potent, dual PIM and FLT3-ITD inhibitor with Kd of 2/2/3 nM for PIM1/2/3, Kd of 160/16 nM for FLT3-WT/FLT3-ITD, respectively; exhibits significantly broader on-target activity in AML cell lines (MV-4-11 GI50=20 nM) and primary AML blasts than selective FLT3-ITD or PIM inhibitors, decreases viability of AML cells with FLT3-TKD mutations associated with resistance to selective FLT3-ITD inhibitors; inhibits the growth of a broad panel of AML cell lines in xenograft models.Blood Cancer Phase 2 Clinical
-
In VitroIn MOLM-13 and to a lesser extent in MV4-11 cells, a dose-dependent disruption of cell cycle with especially pronounced depletion of the S phase after treatment with SEL24-B489, accompanied by PARP cleavage and apoptosis was observed.SEL24-B489 causes a profound inhibition of S6 (S235/236), but has little effect on PI3K/mTOR signaling.SEL24-B489 inhibits STAT5 (Ser726) and reduced expression of MCL1, whereas none of the selective inhibitors altered c-MYC abundance or induced PARP cleavage. Cell Viability AssayCell Line:AZD1208, AC220 and AraC in AML cell lines.Concentration:0-10 μM.Incubation Time:72 h. Result:Decreased viability.
-
In VivoSEL24-B489 (25-100 mg/kg, orally) exhibited activity in AML in vivo models.SEL24-B489 induces apoptosis of DLBCL cell lines in low/sub-micromolar concentrations and exhibits activity in a xenograft model. Animal Model:SCID/beige mice bearing MV-4-11 tumors (FLT3-ITD+).Dosage:50, 75 and 100 mg/kg.Administration:Orally, twice daily.Result:Marked dose – dependent tumor reduction (67%, 74% and 82% tumor growth inhibition (TGI) for 50, 75 and 100 mg/kg daily doses, respectively).
-
SynonymsSEL24
-
PathwayJAK/STAT Signaling
-
TargetPim
-
RecptorPim
-
Research AreaCancer
-
IndicationBlood cancer
Chemical Information
-
CAS Number1616359-00-2
-
Formula Weight446.143
-
Molecular FormulaC15H18Br2N4O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 25 mg/mL (56.04 mM)
-
SMILESCC(N1C(C2CCNCC2)=NC3=C([N+]([O-])=O)C(Br)=C(Br)C=C31)C.[H]Cl
-
Chemical Name5,6-dibromo-4-nitro-2-(piperidin-4-yl)-1-(propan-2-yl)-1H-1,3-benzodiazole
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Czardybon W, et al. Oncotarget. 2018 Mar 30;9(24):16917-16931.
2. Bia?opiotrowicz E, et al. J Cell Mol Med. 2018 Apr 17. doi: 10.1111/jcmm.13632.
3. Szyd?owski M, et al. Blood. 2017 Sep 21;130(12):1418-1429.
molnova catalog



related products
-
Pim1/AKK1-IN-1
A potent, multikinase inhibitor and also inhibits MPSK1 and TNIK.
-
K00135
K00135 is a selective inhibitor of Pim kinases and can be used in studies about gastric cancer and antileukemic therapeutics.
-
Taprenepag
Taprenepag (CP-544326) is a potent and selective prostaglandin E2 receptor agonist (EC50 = 2.8 nM).